| Literature DB >> 34579425 |
Kunle Okaiyeto1, Ayodeji Osmund Falade2, Oluwafemi Omoniyi Oguntibeju1.
Abstract
Clerodendrum volubile is an underutilized leafy vegetable consumed in some parts of Nigeria. The interest in C. volubile has continued to increase due to its multipurpose values, including traditional uses, nutritional properties, and some therapeutic potentials; however, the pharmacological prospects of the plant are yet to be fully explored. Therefore, in the present review, different databases such as PubMed, Scopus, Web of Science, Google Scholar, etc. were explored to retrieve publications used to write this review. The pharmacological potentials of C. volubile, such as anticancer, antioxidant, antiviral, antimicrobial, anti-inflammatory, hepatoprotective, antidiabetic, and anti-hypertensive properties, were highlighted. The toxicological potential of the plant is also discussed. Proposed mechanisms that underline its biological activities include modulation of redox homeostasis, leading to decreased oxidative stress; down-regulation of matrix metalloproteinase-9 (MMP-9) expression; inhibition of key enzymes implicated in diabetes mellitus, hypertension, and neurological diseases; and inhibition of oxidative burst and inflammatory cytokines. Furthermore, the prospect of endophytes from C. volubile as a bioresource to produce novel therapeutic agents, as well as the development of nanotherapeutics from the plant extracts and its phytoconstituents, are discussed. In conclusion, C. volubile possesses an enormous number of possible pharmacological properties and therapeutic potentials waiting to be explored.Entities:
Keywords: Clerodendrum volubile; leafy vegetable; magic leaf; nutritional properties; pharmacological potentials
Year: 2021 PMID: 34579425 PMCID: PMC8472598 DOI: 10.3390/plants10091893
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Clerodendrum volubile (Source: [16]).
Pharmacological potentials of C. volubile reported from previous studies in the literature.
| Pharmacological Activity | Mechanism of Actions | Reference |
|---|---|---|
| Antioxidant | Free radical scavenging and chelation of metal ions involved in redox metabolism; increase in endogenous antioxidant enzymes, such as GSH level, SOD, catalase, and GPx activities with a concomitant reduced. | [ |
| Antidiabetic | Inhibition of α-glucosidase and amylase, key enzymes linked to T2D. | [ |
| Anticancer | Inhibits cell proliferation, arrests cell cycle progression, down-regulates MMP-9 expression, and attenuates oxidative stress. | [ |
| Antihypolipidemia | Lowers plasma cholesterol, LDL, vLDL, and triglyceride levels, as well as increases HDL level. | [ |
| Antihypertensive | Inhibits ACE by chelating its hydroxyl groups with the Zn2+ moiety of ACE and inhibiting vasoconstriction of the blood vessels. | [ |
| Hepatoprotective | Decreases liver biomarker enzymes such as AST, ALT, ALP, and TB levels; improves hepatic architecture. | [ |
| Antiinflammatory | Quenches polymorphonuclear neutrophils’ respiratory oxidative bursts; suppression of T-cell proliferation; inhibition of in vitro lipoxygenase, cyclooxygenase, and xanthine oxidase. | [ |
| Neutroprotective | Inhibition of cholinergic and monoaminergic enzymes such as acetylcholisterases, modulation of the redox homeostasis, mitigates against oxidative stress. | [ |